Header Logo

Connection

BRADY MOFFETT to Dose-Response Relationship, Drug

Back to Details
This is a "connection" page, showing publications BRADY MOFFETT has written about Dose-Response Relationship, Drug.
BRADY MOFFETT
Connection Strength
1.553
Dose-Response Relationship, Drug
  1. Antithrombin Population Pharmacokinetics in Pediatric Ventricular Assist Device Patients. Pediatr Crit Care Med. 2019 12; 20(12):1157-1163.
    View in: PubMed
    Score: 0.126
  2. Population pharmacokinetic analysis of vancomycin in pediatric continuous renal replacement therapy. Eur J Clin Pharmacol. 2019 Aug; 75(8):1089-1097.
    View in: PubMed
    Score: 0.120
  3. Population Pharmacokinetics of Vancomycin in Pediatric Extracorporeal Membrane Oxygenation. Pediatr Crit Care Med. 2018 10; 19(10):973-980.
    View in: PubMed
    Score: 0.116
  4. Fosphenytoin Population Pharmacokinetics in the Acutely Ill Pediatric Population. Pediatr Crit Care Med. 2018 08; 19(8):748-754.
    View in: PubMed
    Score: 0.115
  5. Phenobarbital population pharmacokinetics across the pediatric age spectrum. Epilepsia. 2018 07; 59(7):1327-1333.
    View in: PubMed
    Score: 0.114
  6. The "Ideal" Body Weight for Pediatric Gentamicin Dosing in the Era of Obesity: A Population Pharmacokinetic Analysis. Ther Drug Monit. 2018 06; 40(3):322-329.
    View in: PubMed
    Score: 0.114
  7. Population pharmacokinetics of human antithrombin concentrate in paediatric patients. Br J Clin Pharmacol. 2017 Nov; 83(11):2450-2457.
    View in: PubMed
    Score: 0.107
  8. Spironolactone effect on potassium supplementation in paediatric cardiac intensive care patients. J Clin Pharm Ther. 2017 Aug; 42(4):433-437.
    View in: PubMed
    Score: 0.105
  9. Efficacy of sequential nephron blockade with intravenous chlorothiazide to promote diuresis in cardiac intensive care infants. Cardiol Young. 2017 Aug; 27(6):1104-1109.
    View in: PubMed
    Score: 0.102
  10. Impact of Body Habitus on Phenytoin Levels Following Fosphenytoin Loading Dose in Pediatric Patients. Ther Drug Monit. 2015 Dec; 37(6):772-5.
    View in: PubMed
    Score: 0.096
  11. Response to warfarin therapy in obese pediatric patients dosed according to institutional guidelines. J Pediatr Hematol Oncol. 2014 Nov; 36(8):e487-9.
    View in: PubMed
    Score: 0.089
  12. Heparin dosing in obese pediatric patients in the cardiac catheterization laboratory. Ann Pharmacother. 2011 Jul; 45(7-8):876-80.
    View in: PubMed
    Score: 0.071
  13. High-dose sotalol is safe and effective in neonates and infants with refractory supraventricular tachyarrhythmias. Pediatr Cardiol. 2011 Oct; 32(7):896-903.
    View in: PubMed
    Score: 0.070
  14. Vancomycin dosing in obese pediatric patients. Clin Pediatr (Phila). 2011 May; 50(5):442-6.
    View in: PubMed
    Score: 0.068
  15. Gentamicin dosing for pediatric patients with congenital heart disease. Pediatr Cardiol. 2010 Aug; 31(6):761-5.
    View in: PubMed
    Score: 0.065
  16. Therapeutic levels of intravenous procainamide in neonates: a retrospective assessment. Pharmacotherapy. 2006 Dec; 26(12):1687-93.
    View in: PubMed
    Score: 0.051
  17. Antithrombin Concentrate Use in Children Receiving Unfractionated Heparin for Acute Thrombosis. J Pediatr. 2015 Sep; 167(3):645-9.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.